To remain competitive in today’s global economy, medical technology companies are moving towards the creation and adaptation of new products from multiple technologies. Successful companies are mixing up 
former “silos” – bio-pharmaceuticals, medical devices, nanotechnology/advanced materials and ICT – to develop innovative partnerships and products for a changing healthcare marketplace.
YORKbiotech, a regional innovation network for biotechnology-related industries, is offering entrepreneurs – including York faculty – a chance to learn from leaders of change in the industry how to create and exploit new markets at a conference Nov. 3 on Convergent Medical Technologies (CMT).
The full-day conference will feature sessions on converging new technologies in industry and medicine; business success stories; legal, regulatory and ethical issues; and commercial opportunities in both public and private sectors.
Stan Shapson, vice-president of research & innovation at York, will make the opening remarks. Along with a panel discussions and presentations, there will be two keynote speakers.
John Abele (right), founding CEO of Boston Scientific Inc., will give a talk, titled “Converging or Crashing? Silo Wars and Turf Wars as Disciplines are Merged, Modified and Integrated.” And Steven Arless (left), president, 
CEO and director of CryoCath, will tell how his company developed in his talk on “Bringing Together IT and Medical Device Technologies – The CryoCath Story.”
YORKbiotech promotes collaboration among its public- and private-sector members to create new technologies, discoveries, patents and spin-off companies in York Region.
For details about registration, program schedule and attendees, see the CMT link on the Yorkbiotech Web site. Need more information? Contact conference coordinator Nicole Mulholland at 416-843-9322 or nicole.mulholland@gmail.com.